NCT05841147 is a Phase 4 clinical trial of Tirofiban in Intracranial Aneurysm, sponsored by Lu Hua.

Who is sponsoring NCT05841147?

NCT05841147 is sponsored by Lu Hua.

What drugs are being tested in NCT05841147?

Interventions in NCT05841147: Tirofiban, normal saline.

What condition does NCT05841147 study?

NCT05841147 studies Intracranial Aneurysm.

Is NCT05841147 still recruiting?

NCT05841147 is currently status unknown. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT05841147

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban

Status unknown Phase 4 Last updated 3 May 2023

What this trial tests

Phase 4 trial testing Tirofiban in Intracranial Aneurysm in 70 participants. Status unknown.

Timeline

25 April 2023

Primary endpoint
31 July 2023

31 August 2023

Quick facts

Lead sponsor	Lu Hua
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	70
Start date	25 April 2023
Primary completion	31 July 2023
Estimated completion	31 August 2023
Sites	1 location across China

Drugs / interventions tested

Tirofiban (TIROFIBAN) — full drug profile →
normal saline

Conditions studied

Intracranial Aneurysm — all drugs for Intracranial Aneurysm →

Sponsor

Lu Hua — full company profile →

Who can join

Adults 18 to 75, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.The main questions it aims to answer are: * Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms？ * What dose of tirofiban is safe and effective?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tirofiban

Trials testing the same drug.

NCT07493577 — Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2) · Phase 1, PHASE2 · not yet recruiting
NCT05225961 — ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem · Phase 4 · completed
NCT07379190 — HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) · Phase 3 · not yet recruiting
NCT07111806 — Intravenous Tirofiban After Delayed Thrombolysis in Stroke · Phase 3 · not yet recruiting
NCT07290751 — Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke · Phase 4 · recruiting

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
NCT06588543 — Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping · recruiting
NCT05831202 — SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial · Phase 3 · active not recruiting
NCT06416657 — General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Usin · NA · recruiting

Other Lu Hua trials

Trials by the same sponsor.

NCT06427044 — Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Co · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05841147 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lu Hua
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05841147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing